AKBA Price / Book | AKEBIA THERAPEUTICS, INC.

AKEBIA THERAPEUTICS, INC. (AKBA) Price / Book

2026-09-03: Price/Book Ratio 10.86.
2026-06-30: Price/Book Ratio 12.38.
2026-03-31: Price/Book Ratio 13.6.
2025-12-31: Price/Book Ratio 13.1.

Historical market capitalization divided by filed shareholder equity.

Available history: 2014-03-31 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	10.86
2026-06-30	12.38
2026-03-31	13.6
2025-12-31	13.1
2025-09-30	17.41
2025-06-30	32.76
2025-03-31	20.44
2022-12-31	20.31
2022-09-30	7.04
2022-06-30	1.1
2022-03-31	5.83
2021-12-31	5.41
2021-09-30	3.67
2021-06-30	3.68
2021-03-31	2.51
2020-12-31	1.67
2020-09-30	1.13
2020-06-30	5.25
2020-03-31	2.49
2019-12-31	1.95
2019-09-30	1
2019-06-30	1.11
2019-03-31	1.69
2018-12-31	1.02
2018-09-30	3.53
2018-06-30	3.42
2018-03-31	2.75
2017-12-31	5.78
2017-09-30	9.3
2017-06-30	10.71
2017-03-31	11.67
2016-12-31	5.9
2016-09-30	3.44
2016-06-30	2.13
2016-03-31	2.04
2015-12-31	3.02
2015-09-30	2.01
2015-06-30	1.98
2015-03-31	2.4
2014-12-31	2.28
2014-09-30	3.95
2014-06-30	4.63
2014-03-31	3.1

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Lyell Immunopharma, Inc. (LYEL)	United States	$0.248B	-1.32
Pyxis Oncology, Inc. (PYXS)	United States	$0.244B
Greenwich LifeSciences, Inc. (GLSI)	United States	$0.267B	-15.02
Entrada Therapeutics, Inc. (TRDA)	United States	$0.243B	-1.73
Cue Biopharma, Inc. (CUE)	United States	$0.243B	-1.01
MACROGENICS INC (MGNX)	United States	$0.242B	-20.11
Mereo BioPharma Group plc (MREO)		$0.269B	-9.41
Camp4 Therapeutics Corp (CAMP)	United States	$0.240B	-2.12
Sionna Therapeutics, Inc. (SION)	United States	$0.236B	-20.37
SIGA TECHNOLOGIES INC (SIGA)	United States	$0.234B	-93.33